Back to Newsroom

Novavax to Make Multiple Presentations at RSV Vaccines for the World

GAITHERSBURG, Md., Nov. 16, 2015 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Novavaxrepresentatives will be making multiple oral presentations at the RSV Vaccines for the World conference, November 18-20, 2015 in La Jolla, California.

Click here to read more